Email Updates

Search form

You are here

Trial Summary Table

Trial Name Phase Start Date Sponsors Countries Population Candidate(s) Status Expected Completion Date
Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative Adults (CHARM-03) I Tuesday, January 13, 2015 IPM, NIAID, NIH United States of America Women, Men Maraviroc Completed March 2016
Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring (TDF IVR-002) I Thursday, January 5, 2017 Albert Einstein College of Medicine of Yeshiva University United States of America, Kenya Women TDF Stopped Early December 2018
Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of HSV and HIV (VAST) I Monday, January 4, 2016 LeafBio, Inc., National Institute of Allergy and Infectious Diseases (NIAID), Boston University, The Miriam Hospital United States of America Women VRC01 Completed October 2018
Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy Women I Thursday, October 5, 2017 United States of America Women GRFT Completed August 2018
The Quatro Study Open Label Wednesday, November 11, 2015 CONRAD South Africa, Zimbabwe Women Completed May 2018
TRIO Study (Tablets, Rings, and Injectables as Options for women) Other Saturday, November 15, 2014 BMGF Kenya, South Africa Women Completed May 2016

Pages